Bhandari, Jayant, et al. « Compound 186 Is a Negative Allosteric Modulator of Dopamine D2 Receptors: Implications for Improving Schizophrenia Therapy ». The Meducator, vol. 1, nᵒ 22, mai 2013, doi:10.15173/m.v1i22.818.